Adalimumab API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
Country of origin
Follow us
Distributor
Produced in:
Established in: 2005
MOQ: -
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
+ 0
All certificates
Replies quickly
Producer
+ 0
All certificates
Replies slower than most
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Adalimumab API 331731-18-1?
- Description:
- Here you will find a list of producers, manufacturers and traders of Adalimumab. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Adalimumab
- Synonyms:
- Cas Number:
- 331731-18-1
- DrugBank number:
- DB00051
- Unique Ingredient Identifier:
- FYS6T7F842
About Adalimumab
Do you want to know more about Adalimumab? You can find a small explanation about it here. Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor It was originally launched by Abbvie in the USA and approved in 2002 by the FDA This drug is frequently known as Humira. It is produced by recombinant DNA technology using a mammalian cell expression system. This drug is available in a prefilled syringe form and convenient pen form for subcutaneous self-administered doses A new biosimilar to adalimumab, named adalimumab-adaz, was approved by the FDA on October 31, 2018.
This biosimilar is known as Hyrimoz, and is a trademark of Novartis AG.
You can find more info about this product by clicking on the DB ID above.
Adalimumab is a type of Iodides
Iodides are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the development and formulation of various medications. These compounds contain iodine, a halogen element known for its diverse biological properties and therapeutic applications. Iodides are widely used in the pharmaceutical industry due to their ability to enhance drug stability, solubility, and bioavailability.
One of the primary applications of iodides is in the treatment of thyroid disorders. Iodine is an essential component in the synthesis of thyroid hormones, making iodides valuable in addressing conditions such as hypothyroidism and goiter. By supplementing iodine levels in the body, iodides aid in regulating thyroid function and restoring hormonal balance.
Furthermore, iodides are utilized in radiographic imaging procedures. Iodinated contrast agents, which contain iodides, are administered to enhance the visibility of internal organs and blood vessels during medical imaging tests like computed tomography (CT) scans. These contrast agents, injected or ingested, help improve the diagnostic accuracy by providing clear and detailed images.
In addition to their therapeutic applications, iodides are utilized in the production of a variety of drugs, including antiseptics, antifungals, and expectorants. Their antimicrobial properties make them effective in treating infections caused by bacteria, fungi, and certain parasites. Iodides also possess expectorant qualities, aiding in the expulsion of mucus and alleviating respiratory congestion.
Overall, iodides are a vital subcategory of pharmaceutical APIs, offering significant benefits in the treatment of thyroid disorders, radiographic imaging, and the development of various therapeutic medications.
Adalimumab (Iodides), classified under Anti-Thyroid Agents
Anti-thyroid agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of thyroid disorders. These agents are specifically designed to target and inhibit the production or release of thyroid hormones in the body.
One commonly used anti-thyroid agent is propylthiouracil (PTU). PTU works by interfering with the synthesis of thyroid hormones within the thyroid gland, thereby reducing their production. Another widely used anti-thyroid agent is methimazole, which also acts by inhibiting thyroid hormone synthesis. These agents are typically prescribed for individuals with hyperthyroidism, a condition characterized by an overactive thyroid gland that produces an excessive amount of thyroid hormones.
Anti-thyroid agents are available in various forms, including tablets and solutions for oral administration. The dosage and duration of treatment may vary depending on the severity of the condition and individual patient factors.
It's important to note that anti-thyroid agents should be used under the guidance and supervision of a healthcare professional, as they may have potential side effects. These can include allergic reactions, liver toxicity, and blood disorders. Regular monitoring of thyroid function and liver function is typically recommended during treatment.
In summary, anti-thyroid agents are a class of pharmaceutical APIs used in the management of thyroid disorders. They work by inhibiting the production or release of thyroid hormones and are available in different formulations for oral administration. Proper medical guidance is essential for the safe and effective use of these agents.
Adalimumab manufacturers | traders | suppliers
We have 2 companies offering Adalimumab produced in 2 different countries.
Get in contact with the supplier of your choice:
- LGM Pharma from United States, product country of origin World
- Sandoz from Austria, product country of origin Austria
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
